Autopsy report · NCT02933814

Liposomal Bupivacaine in Ambulatory Hand Surgery

“Inadequate number of subjects meet study criteria”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 3

Sponsor

Loma Linda University

Sponsor type

University, hospital or other

Conditions

Pain

Interventions

Liposomal Bupivicaine

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Infliximab Top-down in Pediatric Crohn
  “Not enough study subjects” (79% match in meaning)
• Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis Patients
  “The number of enrolled subjects did not meet the goal during the study” (75% match in meaning)
• PK Intravenous Lidocaine Infusion
  “Lack of available study participants.” (73% match in meaning)
• Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension
  “Failure to enroll a suitable number of qualified subjects.” (72% match in meaning)
• Gastric Accommodation and Gastroesophageal Reflux
  “the study failed in recruiting the required number of subjects (sample size) during its period” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.